Cantor Fitzgerald Maintains Overweight on INVA Innoviva, Inc Feb 26 2026
Cantor Fitzgerald maintains Overweight on INVA with PT $32. INVA analyst rating updated Feb 26, 2026
Cantor Fitzgerald maintains Overweight on INVA with PT $32. INVA analyst rating updated Feb 26, 2026
TARMAT.NS stock jumps 19.99% intraday to INR 64.89 on heavy volume; Meyka AI forecasts show downside risk, see price targets and outlook.
UBS stock today: Blocher urges US and Asia spin-offs while Keller-Sutter supports equity-funded foreign units, implying about $25B capital. What this means for Swiss investors.
ARYN.SW stock update ahead of Mar 2 earnings; read our earnings spotlight and Meyka AI forecast
Most-active update on 9432.T stock: NTT closes JPY 152.10 on 27 Feb 2026 with heavy volume and a mixed valuation outlook
After-hours volume spike in 3031.HK stock on HKSE 27 Feb 2026. **19,500** shares traded and quick Meyka forecast
Criminal defense attorney searches surge as the Kouri Richins trial spotlights fentanyl testimony. We explain demand drivers, ad windows, and steps for firms and consumers today.
S63.SI stock trades S$10.02 after hours on 27 Feb 2026. Meyka AI forecast and grade, outlook to S$13.22, risks and valuation in SGD
Pre-market: GBAR.TO stock jumps to C$0.01 (+100%) on TSX 27 Feb 2026; review liquidity, metrics, and Meyka forecast
RSH.AX stock at A$0.033 on 27 Feb 2026; oversold setup may trigger a short-term bounce, model target A$0.07